Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients

被引:12
作者
Altun, B
Yilmaz, R
Kahraman, S
Gençtoy, G
Arici, M
Önalan, O
Oto, A
Hayran, M
Bakkaloglu, M
Yasavul, Ü
Turgan, Ç
机构
[1] Hacettepe Univ, Fac Med, Dept Internal Med, Div Nephrol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Cardiol, TR-06100 Ankara, Turkey
[3] Hacettepe Univ, Fac Med, Dept Radiol, TR-06100 Ankara, Turkey
[4] Hacettepe Univ, Fac Med, Dept Canc Epidemiol, TR-06100 Ankara, Turkey
[5] Hacettepe Univ, Fac Med, Dept Urol, TR-06100 Ankara, Turkey
关键词
cardiovascular disease; cytokine; transplantation;
D O I
10.1111/j.1432-2277.2005.00118.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Cardiovascular events are the leading causes of morbidity and mortality in renal transplant recipients (RTR). Given the role of inflammation in atherosclerosis, the contribution of functional polymorphisms of cytokines to cardiovascular diseases (CVD) was assessed in RTR in this study. Polymorphisms of tumour necrosis factor alpha (TNF-alpha) gene [-308 (G -> A), -238 (G -> A)], interleukin-10 (IL-10) gene [-1082(A -> G), -819 (T -> C)], -592 (A -> C), transforming growth factor beta 1 (TGF-beta 1) gene [codon 10 (T -> C), codon 25 (G -> C)], carotis intima media thickness (CIMT), left ventricular mass index (LVMI), 24-h ambulatory blood pressure and serum lipoprotein homocysteine level, erythrocyte sedimentation rate, serum C-reactive protein (CRP) and serum fibrinogen level of RTR were determined. Seventy-two RTR (26 cadaveric allograft, 46 living-related allograft, 43 male, 29 female) were included in this study. LVMI were similar in TNF-alpha, IL-10 and TGF-beta 1 genotypes. Right and left CIMT were higher in TT genotype (n = 16) than CT (n = 46) and CC (n = 10) genotypes of TGF-beta 1 codon 10 (T -> C) gene polymorphism (RCIMT, 7.7 +/- 2.2 mm vs. 7.0 +/- 1.4 mm vs. 5.9 +/- 1.4 mm, P = 0.025; LCIMT, 8.5 +/- 2.5 mm vs. 7.0 +/- 1.3 mm vs. 6.1 +/- 1.2 mm, P = 0.002). Lipoprotein (a) level of TT genotype (35.5 +/- 22.5 mg/dl) was higher than CC (4.1 +/- 2.8 mg/dl) and CT (20.4 +/- 11.2 mg/dl) genotypes of TGF-beta 1 codon 10 (T -> C) gene polymorphism (P = 0.037). High producers of cytokine IL-10 -1082 [GG (n = 22) vs. AA + AG (n = 50)] and low producers of TGF-beta codon 25 [GC + CC (n = 17) vs. GG (n = 55)] had lower IMT of carotid artery but the difference did not reach statistical significance (P > 0.05). The CIMT of renal transplant patients was similar in IL-10 (-819, -592) and TNF-alpha (-308, -238) genotypes. No difference was observed in 24-h ambulatory blood pressure levels, serum lipoproteins, plasma homocysteine level, erythrocyte sedimentation rate, serum CRP, serum fibrinogen level in IL-10, TNF-alpha and TGF-beta 1 genotypes. Besides the well-known factors, TGF-beta 1 gene polymorphisms might play a role in CVD in RTR even at early stages of asymptomatic atherosclerosis.
引用
收藏
页码:681 / 689
页数:9
相关论文
共 50 条
[41]   Circulating Advanced Glycation Endproducts and Long-Term Risk of Cardiovascular Mortality in Kidney Transplant Recipients [J].
Sotomayor, Camilo G. ;
Gomes-Neto, Antonio W. ;
van Londen, Marco ;
Gans, Rijk O. B. ;
Nolte, Ilja M. ;
Berger, Stefan P. ;
Navis, Gerjan J. ;
Rodrigo, Ramon ;
Leuvenink, Henri G. D. ;
Schalkwijk, Casper G. ;
Bakker, Stephan J. L. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (10) :1512-1520
[42]   Is low pre-transplant parathyroid hormone a risk marker for cardiovascular disease in long-term follow-up of renal transplant recipients? [J].
Elin Isaksson ;
Martin Almquist ;
Astrid Seeberger ;
Gunnar Sterner .
Clinical and Experimental Nephrology, 2018, 22 :1188-1197
[43]   Cardiovascular calcifications in kidney transplant recipients [J].
Podesta, Manuel Alfredo ;
Cucchiari, David ;
Ciceri, Paola ;
Messa, Piergiorgio ;
Torregrosa, Jose-Vicente ;
Cozzolino, Mario .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (11) :2063-2071
[44]   Aortic calcifications and arterial stiffness as predictors of cardiovascular events in incident renal transplant recipients [J].
Claes, Kathleen J. ;
Heye, Sam ;
Bammens, Bert ;
Kuypers, Dirk R. ;
Meijers, Bjoern ;
Naesens, Maarten ;
Vanrenterghem, Yves ;
Evenepoel, Pieter .
TRANSPLANT INTERNATIONAL, 2013, 26 (10) :973-981
[45]   Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients [J].
Buraczynska, Monika ;
Ksiazek, Piotr ;
Zukowski, Pawel ;
Benedyk-Lorens, Ewa ;
Orlowska-Kowalik, Grazyna .
CLINICAL IMMUNOLOGY, 2009, 132 (02) :285-290
[46]   The extent and analysis of cytokine and cytokine receptor gene polymorphism [J].
Keen, LJ .
TRANSPLANT IMMUNOLOGY, 2002, 10 (2-3) :143-146
[47]   Impact of cinacalcet pre-transplantation on mineral metabolism in renal transplant recipients [J].
Sharma, Ashish K. ;
Masterson, Rosemary ;
Holt, Stephen G. ;
Tan, Sven-Jean ;
Hughes, Peter D. ;
Chu, Melissa ;
Jayadeva, Pavithra ;
Toussaint, Nigel D. .
NEPHROLOGY, 2016, 21 (01) :46-54
[48]   Infectious complications in renal transplant recipients [J].
Parasuraman, Ravi ;
Yee, Jerry ;
Karthikeyan, Vanji ;
del Busto, Ramon .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2006, 13 (03) :280-294
[49]   Prostate cancer in renal transplant recipients [J].
Kleinclauss, Francois ;
Gigante, Marc ;
Neuzillet, Yann ;
Mouzin, Marc ;
Terrier, Nicolas ;
Salomon, Laurent ;
Iborra, Francois ;
Petit, Jacques ;
Cormier, Luc ;
Lechevallier, Eric .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (07) :2374-2380
[50]   Isoniazid hepatotoxicity in renal transplant recipients [J].
Antony, SJ ;
Ynares, C ;
Dummer, JS .
CLINICAL TRANSPLANTATION, 1997, 11 (01) :34-37